Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Condition: Immunologic Deficiency SyndromesIntervention: Biological: GC5107Sponsors: Green Cross Corporation; ParexelNot yet recruiting - verified May 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2016 Category: Research Source Type: clinical trials